Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Anesthesiology
|
December 1, 1988
Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor
I S Segal, R G Vickery, J K Walton, et al.
Life Sciences
|
January 1, 1988
L-phenylisopropyladenosine (L-PIA) diminishes halothane anesthetic requirements and decreases noradrenergic neurotransmission in rats
B D Birch, G L Louie, R G Vickery, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist
Pamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.
Molecular Pharmacology
|
March 1, 1988
Mechanism of halothane-induced inhibition of isoproterenol-stimulated lipolysis in isolated rat adipocytes
P G Prokocimer, M Maze, R G Vickery, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 17, 2008
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity
J A M Smith, D T Beattie, D Marquess, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists
Lan Jiang, David T Beattie, John R Jacobsen, et al.
Vascular Pharmacology
|
December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954
D T Beattie, D L Higgins, M P Ero, et al.
British Journal of Pharmacology
|
February 13, 2007
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors
R G Vickery, N Mai, E Kaufman, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties
R Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 21, 2013
The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity
Scott R Armstrong, Christina B Campbell, Carrie L Richardson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Anesthesiology
|
December 1, 1988
Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor
I S Segal, R G Vickery, J K Walton, et al.
Life Sciences
|
January 1, 1988
L-phenylisopropyladenosine (L-PIA) diminishes halothane anesthetic requirements and decreases noradrenergic neurotransmission in rats
B D Birch, G L Louie, R G Vickery, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 4, 2013
The in vitro pharmacological profile of TD-1211, a neutral opioid receptor antagonist
Pamela R Tsuruda, Ross G Vickery, Daniel D Long, et al.
Molecular Pharmacology
|
March 1, 1988
Mechanism of halothane-induced inhibition of isoproterenol-stimulated lipolysis in isolated rat adipocytes
P G Prokocimer, M Maze, R G Vickery, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
April 17, 2008
The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity
J A M Smith, D T Beattie, D Marquess, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 14, 2017
Discovery of N-substituted-endo-3-(8-aza-bicyclo[3.2.1]oct-3-yl)-phenol and -phenyl carboxamide series of μ-opioid receptor antagonists
Lan Jiang, David T Beattie, John R Jacobsen, et al.
Vascular Pharmacology
|
December 4, 2012
An in vitro investigation of the cardiovascular effects of the 5-HT(4) receptor selective agonists, velusetrag and TD-8954
D T Beattie, D L Higgins, M P Ero, et al.
British Journal of Pharmacology
|
February 13, 2007
A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors
R G Vickery, N Mai, E Kaufman, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 13, 2013
Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties
R Murray McKinnell, Scott R Armstrong, David T Beattie, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
March 21, 2013
The in vivo pharmacodynamics of the novel opioid receptor antagonist, TD-1211, in models of opioid-induced gastrointestinal and CNS activity
Scott R Armstrong, Christina B Campbell, Carrie L Richardson, et al.
Page
of 3